Egyesült Államok - angol - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 150 mg - lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar i disorder: • treatment of acute manic and mixed episodes in patients 7 years and older [see clinical studies ( 14)] • maintenance treatment in patients 7 years and older [see clinical studies ( 14)] lithium is contraindicated in patients with known hypersensitivity to any inactive ingredient in the lithium carbonate capsule or lithium citrate products [see adverse reactions ( 6)].   risk summary: lithium may cause harm when administered to a pregnant woman. early voluntary reports to international birth registries suggested an increase in cardiovascular malformations, especially for ebstein’s anomaly, with first trimester use of lithium. subsequent case-control and cohort studies indicate that the increased risk for cardiac malformations is likely to be small; however, the data are insufficient to establish

Egyesült Államok - angol - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 300 mg - lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar i disorder: lithium is contraindicated in patients with known hypersensitivity to any inactive ingredient in the lithium carbonate tablet or capsule or lithium citrate products [see adverse reactions (6)]. risk summary: lithium may cause harm when administered to a pregnant woman. early voluntary reports to international birth registries suggested an increase in cardiovascular malformations, especially for ebstein’s anomaly, with first trimester use of lithium. subsequent case-control and cohort studies indicate that the increased risk for cardiac malformations is likely to be small; however, the data are insufficient to establish a drug-associated risk. there are concerns for maternal and/or neonatal lithium toxicity during late pregnancy and the postpartum period [see clinical considerations] . published animal developmental and toxicity studies in mice and rats report an increased incidence of fetal mortality, decreas

Egyesült Államok - angol - NLM (National Library of Medicine)

sun pharmaceutical industries, inc. - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate 300 mg - lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar i disorder: - treatment of acute manic and mixed episodes in patients 7 years and older [see clinical studies (14)] - maintenance treatment in patients 7 years and older [see clinical studies (14)] lithium is contraindicated in patients with known hypersensitivity to any inactive ingredient in the lithium carbonate tablet  [see adverse reactions (6)] . risk summary lithium may cause harm when administered to a pregnant woman. early voluntary reports to international birth registries suggested an increase in cardiovascular malformations, especially for ebstein’s anomaly, with first trimester use of lithium. subsequent case-control and cohort studies indicate that the increased risk for cardiac malformations is likely to be small; however, the data are insufficient to establish a drug-associated risk. there are concerns for maternal and/or neonatal lithium toxicity during late pregnancy and the postpartum period [see cl

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

pharmametics products a division of max biocare pty ltd - cynara scolymus, quantity: 15 mg (equivalent: cynara scolymus, qty 750 mg; equivalent: caffeoylquinic acids calculated as cynarin of cynara scolymus, qty 750 microgram); silybum marianum, quantity: 156.29 mg (equivalent: silybum marianum, qty 10.94 g; equivalent: flavanolignans calculated as silybin, qty 125 mg); d-alpha-tocopheryl acid succinate, quantity: 27.5 mg (equivalent: d-alpha-tocopheryl acid succinate, qty 33 iu); taurine, quantity: 50 mg; schisandra chinensis, quantity: 150 mg (equivalent: schisandra chinensis, qty 750 mg) - tablet, film coated - excipient ingredients: magnesium stearate; povidone; microcrystalline cellulose; crospovidone; maltodextrin; calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; croscarmellose sodium; titanium dioxide; purified talc; triethyl citrate; sodium lauryl sulfate; methacrylic acid copolymer; sodium bicarbonate; macrogol 4000; polyvinyl alcohol; quinoline yellow aluminium lake; carmoisine aluminium lake; lecithin; indigo carmine aluminium lake - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; aids/assists natural body cleansing/detoxification processes ; maintain/support natural liver cleansing/detoxification processes ; helps improve/promote body metabolism/metabolic rate ; maintain/support general health and wellbeing ; maintain/support healthy digestive system function ; maintain/support healthy liver function ; maintain/support liver health

Egyesült Államok - angol - NLM (National Library of Medicine)

20lighter, llc. - chaste tree fruit (unii: 433osf3u8a) (chaste tree - unii:433osf3u8a), alpha lipoic acid (unii: 73y7p0k73y) (.alpha.-lipoic acid - unii:73y7p0k73y), androsterone (unii: c24w7j5d5r) (androsterone - unii:c24w7j5d5r), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), cinchona officinalis bark (unii: s003a158sb) (cinchona officinalis bark - unii:s003a158sb), cynara scolymus leaf (unii: b71ua545de) (cynara scolymus leaf - unii:b71ua545de), go - uses: for the temporary relief of symptoms of food cravings, including: constant appetite, increased or insatiable hunger.*

Egyesült Államok - angol - NLM (National Library of Medicine)

nova homeopathic therapeutics, inc. - silybum marianum seed (unii: u946sh95ee) (silybum marianum seed - unii:u946sh95ee), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), cynara scolymus leaf (unii: b71ua545de) (cynara scolymus leaf - unii:b71ua545de), potassium carbonate (unii: bqn1b9b9ha) (potassium cation - unii:295o53k152), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), phosphorus (unii: 27ylu75u4w) (phosphorus - unii:27ylu75u4w), taraxacum palustre root (unii: gc - suggested use for one or more of the following symptoms: liver congestion due to excessive alcohol, drugs, greasy foods or overeating.